EMA
- Application: EMEA/H/C/006583
- Marketing authorisation holder: Organon N.V.
- Local brand name: Poherdy
- Indication: Treatment of breast cancer in adults.
- Pathway: biosimilar
- Status: approved
🇪🇺 POHERDY in European Union
POHERDY (PERTUZUMAB-DPZB) regulatory status in European Union.
Marketing authorisation
POHERDY in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in European Union
Frequently asked questions
Is POHERDY approved in European Union?
Yes. EMA has authorised it.
Who is the marketing authorisation holder for POHERDY in European Union?
Organon N.V. holds the EU marketing authorisation.